Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 115 Records) |
| Query Trace: Glioma and TP53[original query] |
|---|
| Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
| Transcriptomic Landscape of Lower Grade Glioma Based on Age-Related Non-Silent Somatic Mutations. Current oncology (Toronto, Ont.) 2021 Jun 28 (3): 2281-2295. Park YoungJoon, Park JeongMan, Ahn Ju Won, Sim Jeong Min, Kang Su Jung, Kim Suwan, Hwang So Jung, Han Song-Hee, Sung Kyoung Su, Lim Jaejo |
| Multiomics analysis of tumor mutational burden across cancer types. Computational and structural biotechnology journal 2021 19 5637-5646. Li Lin, Bai Long, Lin Huan, Dong Lin, Zhang Rumeng, Cheng Xiao, Liu Zexian, Ouyang Yi, Ding Kesh |
| TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy. Cancers 2021 11 13 (21): . Noor Humaira, Briggs Nancy E, McDonald Kerrie L, Holst Jeff, Vittorio Oraz |
| Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy. Cancer genetics 2022 9 268-269 55-63. Husain Adil, Mishra Sridhar, Hadi Rahat, Sahu Avnish, Kumari Swati, Rastogi Madhup, Khurana Rohini, Shukla Saumya, Siddiqui Mohammed Haris, Husain Nuzh |
| Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel. Neurologia medico-chirurgica 2022 8 62 (9): 391-399. Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Fujio Shingo, Kirishima Mari, Takigawa Kosuke, Hata Nobuhiro, Toh Keita, Yamamoto Junkoh, Hanaya Ryosuke, Tanimoto Akihide, Yoshimoto Ko |
| Association of TP53 rs1042522 C>G Polymorphism with Glioma Risk in Chinese Children. BioMed research international 2022 8 2022 2712808. Liao Fan, Yuan Li, Zhu Jinhong, Chen Wei, Zhao Yemu, He Ji |
| PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas. Scientific reports 2022 8 12 (1): 14083. Rautajoki Kirsi J, Jaatinen Serafiina, Tiihonen Aliisa M, Annala Matti, Vuorinen Elisa M, Kivinen Anni, Rauhala Minna J, Maass Kendra K, Pajtler Kristian W, Yli-Harja Olli, Helén Pauli, Haapasalo Joonas, Haapasalo Hannu, Zhang Wei, Nykter Mat |
| Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma. Frontiers in immunology 2022 8 13 952413. Cai Jialiang, Wu Suiyi, Zhang Feng, Dai Z |
| Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma. Journal of neuro-oncology 2022 7 159 (2): 397-408. Suzuki Hayato, Ono Takahiro, Koyota Souichi, Takahashi Masataka, Sugai Tamotsu, Nanjo Hiroshi, Shimizu Hiroa |
| TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients. Frontiers in genetics 2022 4 13 720651. Zhang Jian, Liu Minglu, Fang Yujie, Li Jinlong, Chen Yin, Jiao Shuncha |
| Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review. NPJ precision oncology 2022 4 6 (1): 27. Kaubryte Jurgita, Lai Alvina |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment. Frontiers in oncology 2022 12 12 1064127. He Songjiang, Zhang Shi, Yao Yi, Xu Bin, Niu Zhili, Liao Fuben, Wu Jie, Song Qibin, Li Minglun, Liu Zhemi |
| Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
| Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta neuropathologica 2022 10 145 (1): 71-82. Cimino Patrick J, Ketchum Courtney, Turakulov Rust, Singh Omkar, Abdullaev Zied, Giannini Caterina, Pytel Peter, Lopez Giselle Yvette, Colman Howard, Nasrallah MacLean P, Santi Mariarita, Fernandes Igor Lima, Nirschl Jeff, Dahiya Sonika, Neill Stewart, Solomon David, Perez Eilis, Capper David, Mani Haresh, Caccamo Dario, Ball Matthew, Badruddoja Michael, Chkheidze Rati, Camelo-Piragua Sandra, Fullmer Joseph, Alexandrescu Sanda, Yeaney Gabrielle, Eberhart Charles, Martinez-Lage Maria, Chen Jie, Zach Leor, Kleinschmidt-DeMasters B K, Hefti Marco, Lopes Maria-Beatriz, Nuechterlein Nicholas, Horbinski Craig, Rodriguez Fausto J, Quezado Martha, Pratt Drew, Aldape Kenne |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Frontiers in immunology 2022 13 998236. Wang Weichen, Lu Zhichao, Wang Maoyu, Liu Zongheng, Wu Bing, Yang Chengkai, Huan He, Gong Peip |
| Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
| The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas. Neuro-oncology advances 2023 6 5 (1): vdad069. Meenakshi Vij, Raquel T Yokoda, Omid Rashidipour, Ivy Tran, Varshini Vasudevaraja, Matija Snuderl, Raymund L Yong, William S Cobb, Melissa Umphlett, Jamie M Walker, Nadejda M Tsankova, Timothy E Richards |
| lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. Genes 2023 5 14 (5): . Jinxuan Xie, Yi Lin, Yajie Li, Aizhong Fang, Xin Li, Songlin Wang, Wenbin |
| Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
| Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations. Cancer research 2023 2 . Liu Yuxi, Gusev Alexander, Kraft Pet |
| Immunological Role of TP53 Somatic Mutation Classification in Human Cancers. Journal of oncology 2023 2 2023 1904309. Fang Jianfei, Yang Ying, Xie Lina, Yin Wenju |
| Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel. Oncology letters 2023 1 25 (1): 38. Romanidou Ourania, Apostolou Paraskevi, Kouvelakis Kyriakos, Tsangaras Kyriakos, Eliades Alexia, Achilleos Achilleas, Loizides Charalambos, Lemesios Christos, Ioannides Marios, Kypri Elena, Koumbaris George, Papadopoulou Kyriaki, Papathanasiou Athanasios, Rigakos Georgios, Xanthakis Ioannis, Fostira Florentia, Kotoula Vassiliki, Fountzilas George, Patsalis Philippos |
| Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
| Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer. Molecular systems biology 2024 7 . Aidan Flynn, Sebastian M Waszak, Joachim Weischenfel |
| Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases. Acta neuropathologica communications 2024 4 12 (1): 57. Yuji Kibe, Fumiharu Ohka, Kosuke Aoki, Junya Yamaguchi, Kazuya Motomura, Eiji Ito, Kazuhito Takeuchi, Yuichi Nagata, Satoshi Ito, Nobuhiko Mizutani, Yoshiki Shiba, Sachi Maeda, Tomohide Nishikawa, Hiroki Shimizu, Ryuta Sai |
| GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
| TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study. Cancer medicine 2025 1 14 (2): e70533. Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin |
- Page last reviewed:Feb 1, 2024
- Content source: